Mark Roest

PhD, Clinical Director
Synapse Research Institute
Maastricht, Limburg, Netherlands

Presentation(s):

• PB0198 - A novel plasminogen activator anti-fibrin-uPA increases the sensitivity of the plasmin generation assay to regulators of fibrinolysis

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0038 - Low thrombin inactivation capacity is associated with an increased risk of recurrent cardiovascular events in young patients with ischemic stroke

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0345 - The novel variable heavy chain antibody Syn-VWFA1 inhibits platelet von Willebrand factor interaction in solution

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 22.3 - Prothrombin Fragment 2: A Potential Therapeutic Target to Inhibit Antiprothrombin-induced Platelet Activation

  Sunday, June 23, 2024
  15:15 – 15:30 ICT

• PB1411 - Altered whole blood thrombin generation and hyperresponsive platelets associate with thromboembolic events in patients with pancreatic ductal adenocarcinoma

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT